Table 1.

Clinicopathological association of TUG1 and miR-29c expression in pancreatic cancer patients.

Clinicopathological features	No. of cases	TUG1 expression		P value	miR-29c expression		P value
		High	Low		High	Low
Age (years)				0.571			0.547
>60	42	29	13		19	23
≤60	30	21	9		14	16
Gender				0.253			0.525
Female	27	17	10		12	15
male	45	33	12		21	24
Tumour size				0.159			0.509
>5 cm	25	15	10		11	14
≤5 cm	47	35	12		22	25
Clinical stage				0.016			0.039
I + II	48	29	19		18	30
III + IV	24	21	3		15	9
Lymph node status				0.019			0.01
Metastasis	41	33	8		12	29
No metastasis	31	17	14		21	10
Pathological differentiation				0.032			0.042
Well	39	23	16		22	17
Moderately-poorly	33	27	6		11	22